Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Vigario FL"'
Autor:
van Os WL; Department of Supramolecular and Biomaterials Chemistry, Leiden Institute of Chemistry, Leiden University, Leiden, the Netherlands., Wielaert L; Department of Supramolecular and Biomaterials Chemistry, Leiden Institute of Chemistry, Leiden University, Leiden, the Netherlands., Alter C; Division of Pharmaceutical Technology, Department of Pharmaceutical Science, University of Basel, Switzerland., Davidović D; J. Heyrovský Institute of Physical Chemistry of the Czech Academy of Sciences, Prague, Czech Republic., Šachl R; J. Heyrovský Institute of Physical Chemistry of the Czech Academy of Sciences, Prague, Czech Republic., Kock T; Department of Supramolecular and Biomaterials Chemistry, Leiden Institute of Chemistry, Leiden University, Leiden, the Netherlands., González UU; Department of Supramolecular and Biomaterials Chemistry, Leiden Institute of Chemistry, Leiden University, Leiden, the Netherlands., Arias-Alpizar G; Division of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, the Netherlands., Vigario FL; Division of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, the Netherlands., Knol RA; Department of Supramolecular and Biomaterials Chemistry, Leiden Institute of Chemistry, Leiden University, Leiden, the Netherlands., Kuster R; Department of Supramolecular and Biomaterials Chemistry, Leiden Institute of Chemistry, Leiden University, Leiden, the Netherlands., Romeijn S; Division of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, the Netherlands., Mora NL; J. Heyrovský Institute of Physical Chemistry of the Czech Academy of Sciences, Prague, Czech Republic., Detampel P; Division of Pharmaceutical Technology, Department of Pharmaceutical Science, University of Basel, Switzerland., Hof M; J. Heyrovský Institute of Physical Chemistry of the Czech Academy of Sciences, Prague, Czech Republic., Huwyler J; Division of Pharmaceutical Technology, Department of Pharmaceutical Science, University of Basel, Switzerland., Kros A; Department of Supramolecular and Biomaterials Chemistry, Leiden Institute of Chemistry, Leiden University, Leiden, the Netherlands. Electronic address: a.kros@chem.leidenuniv.nl.
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2024 Jul; Vol. 371, pp. 85-100. Date of Electronic Publication: 2024 May 24.
Autor:
Nagy NA; Department of Experimental Immunology, Amsterdam University Medical Centers, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, the Netherlands., Castenmiller C; Department of Experimental Immunology, Amsterdam University Medical Centers, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, the Netherlands., Vigario FL; Division of BioTherapeutics, Leiden Academic Center for Drug Research, Leiden, the Netherlands., Sparrius R; Department of Experimental Immunology, Amsterdam University Medical Centers, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, the Netherlands., van Capel TMM; Department of Experimental Immunology, Amsterdam University Medical Centers, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, the Netherlands., de Haas AM; Department of Molecular Cell Biology and Immunology, Amsterdam University Medical Center, Cancer Center Amsterdam, Amsterdam Institute for Infection and Immunity, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., van Kooyk Y; Department of Molecular Cell Biology and Immunology, Amsterdam University Medical Center, Cancer Center Amsterdam, Amsterdam Institute for Infection and Immunity, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., van Ree R; Department of Experimental Immunology, Amsterdam University Medical Centers, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, the Netherlands; Department of Otorhinolaryngology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands., Tas SW; Department of Experimental Immunology, Amsterdam University Medical Centers, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, the Netherlands; Department of Rheumatology and Clinical Immunology, Amsterdam University Medical Centers, Amsterdam Rheumatology and Immunology Center, University of Amsterdam, Amsterdam, the Netherlands., Geijtenbeek TBH; Department of Experimental Immunology, Amsterdam University Medical Centers, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, the Netherlands., Jiskoot W; Division of BioTherapeutics, Leiden Academic Center for Drug Research, Leiden, the Netherlands., Slütter B; Division of BioTherapeutics, Leiden Academic Center for Drug Research, Leiden, the Netherlands., de Jong EC; Department of Experimental Immunology, Amsterdam University Medical Centers, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, the Netherlands. Electronic address: e.c.dejong@amsterdamumc.nl.
Publikováno v:
Journal of pharmaceutical sciences [J Pharm Sci] 2022 Apr; Vol. 111 (4), pp. 1081-1091. Date of Electronic Publication: 2022 Jan 31.
Autor:
Vigario FL; Division of BioTherapeutics, Leiden Academic Centre for Drug Research, Einsteinweg 55, PO Box 9502, 2300RA Leiden, the Netherlands., Kuiper J; Division of BioTherapeutics, Leiden Academic Centre for Drug Research, Einsteinweg 55, PO Box 9502, 2300RA Leiden, the Netherlands. Electronic address: j.kuiper@lacdr.leidenuniv.nl., Slütter B; Division of BioTherapeutics, Leiden Academic Centre for Drug Research, Einsteinweg 55, PO Box 9502, 2300RA Leiden, the Netherlands.
Publikováno v:
EBioMedicine [EBioMedicine] 2020 Jul; Vol. 57, pp. 102827. Date of Electronic Publication: 2020 Jun 20.